Lynch syndrome (LS) is an autosomal dominant condition characterized by an increased risk of hereditary colorectal, endometrial, ovarian, pancreatic, urinary tract, and gastric cancer.
It is estimated that around 5% of all endometrial cancer (EC) cases are due to an inherited predisposition, of which LS might be the most frequent. The lifetime risk of developing EC in women with LS ranges between 40% and 71% depending on the type of mutation. In many cases, this risk may even exceed their risk of developing colon cancer. Moreover, in 60% of these women, EC will be the first primary malignancy diagnosed and the sentinel diagnosis of the syndrome. Therefore, it is essential to identify which women with EC have LS in order to allow implementation of individualized screening and preventive strategies.
Tumori 2016; 102(6): 548 - 554
Article Type: REVIEW
AuthorsElena Aguirre, Begoña Graña, Miguel Boudet, Judith Balmaña
- • Accepted on 03/06/2015
- • Available online on 15/07/2015
This article is available as full text PDF.
- Aguirre, Elena [PubMed] [Google Scholar] 1, * Corresponding Author (email@example.com)
- Graña, Begoña [PubMed] [Google Scholar] 2
- Boudet, Miguel [PubMed] [Google Scholar] 3
- Balmaña, Judith [PubMed] [Google Scholar] 4
Department of Oncology, Hospital Arnau de Vilanova, Lleida - Spain
Department of Oncology, Complexo Hospitalario a Corula, Galicia - Spain
Department of Digestive, Hospital Arnau de Vilanova, Lleida - Spain
Department of Oncology, Hospital Vall D’Hebron, Barcelona - Spain